Feature
MOTS-c: Where the Evidence Ends
Studies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?
PR Newswire
Hansa Biopharma announces positive Idefirix PAES results presented in the High-Impact Clinical Trials session at ASN Kidney Week
European post-approval study reported one-year graft outcomes and safety after imlifidase transplants.
Key takeaways
- The study reported one-year graft failure-free survival.
- The findings described a selected group of highly sensitised patients.
- Reported tolerability was consistent with prior clinical experience.
